SOURCES SOUGHT
B -- Development and Production of Parenteral Dosage Forms
- Notice Date
- 8/7/2002
- Notice Type
- Sources Sought
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- N02-CM-27007-19
- Response Due
- 9/5/2002
- Point of Contact
- Diane Stalder, Contract Specialist, Phone (301) 435-3822, Fax (301) 402-6699, - MaryAnne Golling, Contracting Officer, Phone (301) 435-3819, Fax (301) 402-6699,
- E-Mail Address
-
ds88b@nih.gov, mg345x@nih.gov
- Description
- The primary objective of this project is to develop and produce Pharmaceutically acceptable parenteral dosage forms of promising new agents with activity against cancer or the HIV virus. Certain agents selected by the NCI, DCTDC, Cancer and AIDS operating committees will be assigned for development and production as parenteral products. Batch sizes will be small development batches (15 batches/2000 vials per year). The capability to develop and manufacture other pharmaceutical dosage form (i.e. large volume parenteral, sterile emulsions, sterile micro-dispersions, etc) is desirable but not essential. Data obtained from the contract will: 1) be used to support IND applications submitted by the National Cancer Institute to the U.S. Food and Drug Administration, 2) be provided to other NCI contractors engaged in large scale dosage form manufacture and analytical evaluation of these dosage forms and 3) be provided to physicians, pharmacists, and nurses and other medical personnel handling these products in a clinical setting. Please submit capability statements by 3:00 PM local time on September 5, 2002 to Diane Stalder at ds88b@nih.gov Limit 20 pages by e-mail
- Record
- SN00135086-W 20020809/020808084749 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |